The role of mechano growth factor in chondrocytes and cartilage defects: a concise review

Acta Biochim Biophys Sin (Shanghai). 2023 May 12;55(5):701-712. doi: 10.3724/abbs.2023086.

Abstract

Mechano growth factor (MGF), an isoform of insulin-like growth factor 1 (IGF-1), is recognized as a typical mechanically sensitive growth factor and has been shown to play an indispensable role in the skeletal system. In the joint cavity, MGF is highly expressed in chondrocytes, especially in the damaged cartilage tissue caused by trauma or degenerative diseases such as osteoarthritis (OA). Cartilage is an extremely important component of joints because it functions as a shock absorber and load distributer at the weight-bearing interfaces in the joint cavity, but it can hardly be repaired once injured due to its lack of blood vessels, lymphatic vessels, and nerves. MGF has been proven to play an important role in chondrocyte behaviors, including cell proliferation, migration, differentiation, inflammatory reactions and apoptosis, in and around the injury site. Moreover, under the normalized mechanical microenvironment in the joint cavity, MGF can sense and respond to mechanical stimuli, regulate chondrocyte activity, and maintain the homeostasis of cartilage tissue. Recent reports continue to explain its effects on various cell types and sport-related tissues, but its role in cartilage development, homeostasis and disease occurrence is still controversial, and its internal biological mechanism is still elusive. In this review, we summarize recent discoveries on the role of MGF in chondrocytes and cartilage defects, including tissue repair at the macroscopic level and chondrocyte activities at the microcosmic level, and discuss the current state of research and potential gaps in knowledge.

Keywords: cartilage defect; chondrocyte; insulin-like growth factor 1; mechano growth factor.

Publication types

  • Review

MeSH terms

  • Cartilage / metabolism
  • Cartilage, Articular* / metabolism
  • Cell Differentiation
  • Chondrocytes / metabolism
  • Humans
  • Insulin-Like Growth Factor I / metabolism
  • Osteoarthritis* / metabolism

Substances

  • Insulin-Like Growth Factor I

Grants and funding

This work was supported by the grants from the National Natural Science Foundation of China (No. 81771047 to J.X.) and the Sichuan Science and Technology Innovation Talent Project (No. 2022JDRC0044 to J.X.).